Working with White, Avient helped to bring his invention to life– the USee™ vision testing system. I can’t thank Avient and its design team enough for donating their time, passion and expertise to help change the world with the gift of clear sight.” Avient aims to guide sustainable philanthropy by working on inventions like the USee™ with organizations committed to making the world a better place.

Nikrant Page 67 United States 36% Europe 36% Canada 2% Asia 20% Latin America 2011 Revenue: $0.6 Billion2011 Revenue: $0.6 Billion SolutionsSolutions At a Glance Appliance 6% Building & Construction 3% Wire & Cable 14% Electrical & Electronics 14%Consumer 21% Packaging 5% Industrial 8% Misc. 3% HealthCare 5% Transportation 21% America 6% 2011 Revenue by Industry Segment2011 Revenue by Industry Segment 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% 12-16% 2006 2007 2008 2009 2010 2011 2015 Operating Income % of Sales Target Expanding ProfitsExpanding Profits Page 68 Value Proposition • GSEM is a global leader providing complete specialty solutions encompassing innovative technologies and services to enable customer success Transformation Highlights • Dramatic turnaround of the Engineered Materials business through mix improvement and specialty focus Value Proposition and Transformation Highlights improvement and specialty focus • GLS acquisition successfully integrated, having more than doubled earnings in 3 years • PolyOne culture and strategy now engrained worldwide • Expansion into healthcare with dedicated resources > $15B Addressable Market Page 69 • Polymer design, formulation and service expertise • Broad, global technology base and regional centers of excellence • Ten innovation centers around the world Key Differentiators • Ten innovation centers around the world • Specialty brand leadership with PolyOne, GLS, NEU and ECCOH • Ability to leverage global key account team Page 70 From Volume Commodity-driven product portfolio To Value Specialty technology and solutions EM North America Transformation Volume Sales Gross Margin $ Mix Transformation – Executing the Strategy 2006 2011 2006 2011 2006 2011 Page 71 $12 $29 Operating Income ($ in millions) • Provided access to new customers in specialized, high-growth markets such as healthcare and consumer • Strategic partner to many of the world’s best-known companies GLS Integration Success 16.9% 8.2% 2007 2011 2007 2011 Working Capital % of Sales • Complementary global footprint provided additional cross-selling opportunities • Opportunity to expand margins and drive working capital improvement while remaining customer-focused Page 72 $1.3 $27.6 2006 2011 Healthcare Revenue • Investment in dedicated healthcare team to drive penetration and growth • Leverage product portfolio globally & win specialty business Areas of Focus $10.5 $117.9 2006 2011 Consumer Revenue 2006 2011globally & win specialty business in targeted markets • Aggressively commercialize specialty innovation platforms • Utilize our innovation centers to influence OEM design (Revenue in $ millions) Page 73 • Carbon Nanotube Formulations � Applications: Semiconductor equipment, hard drives � Customer benefits: Scrap cost reduction and clean conductivity • Thermally Conductive Solutions Applications: Sockets and bulb holders for LED lighting Key Innovations � Applications: Sockets and bulb holders for LED lighting � Customer benefits: Cost reduction, energy saving, and design flexibility • FDA-Regulated TPEs � Applications: Food packaging seals, intravenous delivery systems, medical stoppers, prefilled syringes � Customer benefits: Clean and safe elastomers for highly regulated applications Page 74 Critical Imperatives and 2015 Goal Critical Imperatives • Commercialize critical new technology platforms • Manage the mix as we continue to drive the transformation • Global translation of commercial successes 2015 Goal • 12 - 16% return on sales Page 75 Page 76

Using Geon M5705 material for these seven colors will save an additional $200,000 per year.

IVCC and Avient joined forces to step up the global fight to eradicate malaria. Avient and IVCC created a new medium scale masterbatch production laboratory in China to support research and development into non-registered novel active ingredients for incorporation into long lasting treated nets. Avient has extensive global ability in the formulation development and manufacturing of groundbreaking material solutions to support malaria control, including a technologically advanced anti-mosquito masterbatch for use in long lasting treated nets.

IVCC and Avient joined forces to step up the global fight to eradicate malaria. Avient and IVCC created a new medium scale masterbatch production laboratory in China to support research and development into non-registered novel active ingredients for incorporation into long lasting treated nets. Avient has extensive global ability in the formulation development and manufacturing of groundbreaking material solutions to support malaria control, including a technologically advanced anti-mosquito masterbatch for use in long lasting treated nets.

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...